News Pharmagreen Biotech Inc. OTC Markets

Equities

PHBI

US00922N1046

Delayed OTC Markets Other stock markets 11:11:07 2021-10-05 am EDT			5-day change	1st Jan Change
0.0289 ^USD	-.--%		-4.87%	+172.64%

Feb. 21	Pharmagreen Biotech Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	CI
Jan. 09	Pharmagreen Biotech Inc. Reports Earnings Results for the Full Year Ended September 30, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Pharmagreen Biotech Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	Feb. 20	CI
Pharmagreen Biotech Inc. Reports Earnings Results for the Full Year Ended September 30, 2023	Jan. 08	CI
Sub-Penny Momentum Watchlist (TMGI, BEGI, PHBI, ABQQ)	Nov. 07	AQ
Pharmagreen Biotech Inc. cancelled the transaction announced on November 2, 2022	Nov. 01	CI
PHBI – Pharmagreen Starts Sales of MaxGenomicTM Supplement on Amazon.com and Develops Its Next Pre-Workout Formulation	23-09-05	AQ
Pharmagreen Starts Sales of MaxGenomicTM Supplement on Amazon.Com and Develops Its Next Pre-Workout Formulation	23-09-05	CI
Pharmagreen Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023	23-08-14	CI
Pharmagreen Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023	23-05-19	CI
PHARMAGREEN BIOTECH INC. : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)	23-05-18	AQ
Pharmagreen Biotech Inc. Reports Earnings Results for the First Quarter Ended December 31, 2022	23-02-14	CI
PHARMAGREEN BIOTECH INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	23-02-14	AQ
Pharmagreen Biotech, Inc. Launches Online Sales for Its MaxGenomic(TM) Supplement Product	23-02-08	CI
PHBI Pharmgreen Launches Online Sales for Its MaxGenomic™ Supplement Product	23-02-08	AQ
PHARMAGREEN BIOTECH INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	23-01-17	AQ
Pharmagreen Biotech Inc. Reports Earnings Results for the Full Year Ended September 30, 2022	23-01-17	CI
Pharmagreen Biotech Inc. Auditor Raises 'Going Concern' Doubt	23-01-16	CI
PHARMAGREEN BIOTECH INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Other Events, Financial Statements and Exhibits (form 8-K)	22-12-02	AQ
Pharmagreen Appoints Tyrell Crosby, a Professional Athlete, as Its Honorary Sports Ambassador	22-11-29	AQ
Pharmagreen Biotech Inc. announced that it expects to receive $0.05 million in funding from JanBella Group, LLC	22-11-01	CI
PHBI Pharmagreen Biotech Appoints Ethan Styles as Vice President of Product Research and Development	22-09-22	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Pharmagreen Biotech Inc. OTC Markets

Equities

PHBI

US00922N1046

Summary

Filters